Many growth factor receptors including the epidermal growth factor receptor function through tyrosine kinase activity. The aim of this study was to examine the constitutive level of tyrosine phosphorylation in the normal duodenum and in the hyperproliferative coeliac duodenum. A flow cytometric assay was devised using monoclonal antibody to phosphorylated (but not native) tyrosine residues to determine the levels of tyrosine phosphorylation in both CD3 positive intraepithelial lymphocytes and CD3 negative epithelial cells obtained by EDTA treatment of endoscopically obtained duodenal biopsy specimens. In addition, immunohistochemistry was performed on 18 formalin fixed coeliac duodenal biopsy specimens and eight control specimens. Tyrosine phosphorylation could be detected by flow cytometry on duodenal enterocytes and this expression was up regulated by pretreatment with epidermal growth factor. Tyrosine phosphorylation decreased with progression from the villus to the crypt, however, and was virtually undetectable on crypt enterocytes. Immunohistochemistry of the coeliac duodenum showed virtually absent tyrosine phosphorylation in the crypt. Increased tyrosine phosphorylation was detected in the infiltrating T cells. In conclusion, tyrosine phosphorylation in the duodenum is confined to the non-proliferative villous epithelium and is virtually undetectable in the proliferative crypt compartment. These findings suggest that tyrosine kinase activity is not a significant factor in the regulation of crypt cell proliferation in the human duodenum either in normal subjects or in coeliac disease patients.
A large range of polypeptides, including growth factors such as epithelial growth factors, differentiation factors, and hormones, mediate their biological activity by binding to and activating cell surface receptors with intrinsic tyrosine kinase activity.1 2 Activation of these tyrosine kinase enzymes is usually mediated by receptor oligomerisation with subsequent conformational changes in the catalytic domain, which is normally intracellular.3 The epidermal growth factor receptor (EGFR) is a well characterised receptor with intrinsic tyrosine kinase activity and significant homology to the erb b oncogene.4 It has been reported that epidermal growth factor (EGF) has a significant role in growth promotion of epithelial cells in vitro. In the rat, EGF, either directly or indirectly, is a potent stimulator of intestinal epithelial cell proliferation.5 6 It has also been shown that EGF may have a proliferative effect in vivo in the human neonatal intestine.7 It is notable, however, that when EGF is given intralumenally the results on epithelial proliferation are variable.89 As one of the important sites of release of EGF in the human intestine is through central channels at the villous tip,'0 this might suggest that the effects of intralumenal EGF in the human intestine are limited or are not related to proliferation.
Antibodies to phosphorylated tyrosine residues now permit the assay of tyrosine kinase activity within a cellular system. We have developed a system using monoclonal antibody 1G2"1 to phosphotyrosine residues to study the constitutive values of tyrosine phosphorylation and hence inferentially tyrosine kinase activity in both epithelial cells and T cells by two colour flow cytometry. This monoclonal antibody has previously been used to identify surface and cytoplasmic proteins phosphorylated on tyrosine in response to colony stimulating factor 112 and interleukin 2.13 Flow cytometric studies have shown a linear correlation between values of tyrosine phosphorylation on phosphoamino analysis and results obtained by flow cytometry.14 We have used this technique to examine levels of tyrosine phosphorylation in the human duodenum. In addition, we took patients with coeliac disease as a model for increased crypt cell proliferation and performed immunohistochemistry on duodenal biopsy specimens obtained from both normal subjects and from coeliac disease patients.
Methods

PATIENTS
Duodenal biopsy specimens were obtained endoscopically from the second stage of the duodenum from patients giving informed consent. Patients were receiving endoscopy for dyspeptic symptoms and were all found to have a normal small intestine. Archival formalin fixed material was used for the study of in situ immunohistochemistry. Archival material was obtained from 18 . Positive staining is brown. The normal duodenum has evidence of phosphotyrosine staining on the viUi but staining is reduced with progression into the crypts. In the coeliac duodenum phosphotyrosine expression is minimal on both surface and crypt even within the hyperproliferative middle third of the crypt. Note however, phosphotyrosine expression in both lamina propria and intraepithelial lymphocytes in the coeliac duodenum.
lation evident in the duodenal crypt (Fig 3A,  B) . In the coeliac disease patients, there is minimal tyrosine phosphorylation detected either on the surface epithelium or in the crypts (Fig  3C, D) . In some patients, tyrosine phosphorylation was evident on the surface epithelium. There is, however, clearly little or no tyrosine phosphorylation present in the coeliac crypt. By contrast it is clear that the lymphocytes within the coeliac crypt express significant levels of phosphorylated tyrosine suggesting that these activated lymphocytes are using tyrosine kinases in their pathways of activation. fact, the main cells staining for tyrosine phosphorylation in coeliac disease are the infiltrating intraepithelial lymphocytes. These data cast doubt on the thesis that EGF is the dominant growth factor for human duodenal crypt proliferation. These data are consistent, however, with previous findings that EGF may be secreted by a novel lineage induced by ulceration, which discharges at the villous tip'0 and with the finding that transforming growth factor alpha, which shares the same receptor as EGF is distributed mainly on villous cells. '8 These data suggest that the biological effects of these agents are located mainly in the nonproliferative villous epithelium and further suggest that tyrosine phosphatases, which cleave phosphate groups from tyrosine residues'9 20 In conclusion, we have shown that tyrosine phosphorylation in the human duodenum is at its lowest level at the site of maximal cellular proliferation. EGF does induce tyrosine phosphorylation detectable by flow cytometry in cultured human epithelial cells. These findings strongly suggest that epidermal growth factor is not the dominant factor for epithelial cell proliferation in the adult human duodenum. Secondly, if tyrosine kinases participate in the regulation of epithelial proliferation, then there must be a steady state situation in which there is a dominant effect of tyrosine phosphatases in the dephosphorylation of tyrosine residues on growth factor receptors in the intestine. None the less, we cannot exclude the possibility that EGF is a growth factor in neonatal development7 or after injury or ulceration.'0 30 
